Company & Sponsor Intelligence
Samsung Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed3
Countries1
Therapeutic footprint
alzheimersmigraine_headachemovement_disordersparkinsons
Indexed studies
NCT04595578Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia
movement_disorders · South KoreaNA
movement_disorders · South KoreaNA
NCT02227953A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease
alzheimers · South KoreaNA
alzheimers · South KoreaNA
NCT01198093Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)
alzheimers · South KoreaUNKNOWN
alzheimers · South KoreaUNKNOWN
NCT01023867Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
alzheimers · South KoreaNA
alzheimers · South KoreaNA
NCT03494673Prediction of WMH in Migraine Using a BOLD-CVR Map
migraine_headache · South KoreaUNKNOWN
migraine_headache · South KoreaUNKNOWN
NCT02850159Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease
parkinsons · NA
parkinsons · NA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →